Index by author
Chroust, V.
- InterventionalYou have accessComparison of Stent-Retriever Devices versus the Merci Retriever for Endovascular Treatment of Acute StrokeE. Broussalis, E. Trinka, W. Hitzl, A. Wallner, V. Chroust and M. Killer-OberpfalzerAmerican Journal of Neuroradiology February 2013, 34 (2) 366-372; DOI: https://doi.org/10.3174/ajnr.A3195
Cloft, H.J.
- Review ArticlesOpen AccessReview of 2 Decades of Aneurysm-Recurrence Literature, Part 1: Reducing Recurrence after Endovascular CoilingE. Crobeddu, G. Lanzino, D.F. Kallmes and H.J. CloftAmerican Journal of Neuroradiology February 2013, 34 (2) 266-270; DOI: https://doi.org/10.3174/ajnr.A3032
Comunale, J.P.
- EDITOR'S CHOICEBrainOpen AccessEvaluating CT Perfusion Using Outcome Measures of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid HemorrhageP.C. Sanelli, N. Anumula, C.E. Johnson, J.P. Comunale, A.J. Tsiouris, H. Riina, A.Z. Segal, P.E. Stieg, R.D. Zimmerman and A.I. MushlinAmerican Journal of Neuroradiology February 2013, 34 (2) 292-298; DOI: https://doi.org/10.3174/ajnr.A3225
Ninety-six patients with SAH were evaluated with CT perfusion for cortical deficits and these were correlated with primary (permanent neurologic deficits and infarctions) and secondary (delayed cerebral ischemia manifesting as clinical deterioration) outcome measures. One-third of patients developed permanent neurologic deficits (78% showed CT perfusion defects), infarctions developed in 18% (88% had perfusion defects), and delayed cerebral ischemia was found in 50% (81% had perfusion defects). The most common perfusion abnormalities were reduced CBF and prolonged MTT.
Contessa, G.M.
- BrainYou have accessStructural Brain MR Imaging Changes Associated with Obsessive-Compulsive Disorder in Patients with Multiple SclerosisE. Tinelli, A. Francia, E.M. Quartuccio, M. Morreale, G.M. Contessa, S. Pascucci, E. Sbardella, C. Pozzilli and P. PantanoAmerican Journal of Neuroradiology February 2013, 34 (2) 305-309; DOI: https://doi.org/10.3174/ajnr.A3210
Craufurd, D.
- BrainYou have accessMagnetization Transfer Imaging in Premanifest and Manifest Huntington Disease: A 2-Year Follow-UpS.J.A. van den Bogaard, E.M. Dumas, E.P. Hart, J. Milles, R. Reilmann, J.C. Stout, D. Craufurd, C.R. Gibbard, S.J. Tabrizi, M.A. van Buchem, J. van der Grond and R.A.C. RoosAmerican Journal of Neuroradiology February 2013, 34 (2) 317-322; DOI: https://doi.org/10.3174/ajnr.A3303
Crobeddu, E.
- Review ArticlesOpen AccessReview of 2 Decades of Aneurysm-Recurrence Literature, Part 1: Reducing Recurrence after Endovascular CoilingE. Crobeddu, G. Lanzino, D.F. Kallmes and H.J. CloftAmerican Journal of Neuroradiology February 2013, 34 (2) 266-270; DOI: https://doi.org/10.3174/ajnr.A3032
Cruz, J.P.
- EDITOR'S CHOICEExpedited PublicationYou have accessPipeline Embolization Device in Aneurysmal Subarachnoid HemorrhageJ.P. Cruz, C. O'Kelly, M. Kelly, J.H. Wong, W. Alshaya, A. Martin, J. Spears and T.R. MarottaAmerican Journal of Neuroradiology February 2013, 34 (2) 271-276; DOI: https://doi.org/10.3174/ajnr.A3380
The authors used the Pipeline device to treat 20 patients with acutely ruptured intracranial aneurysms. The most common types of aneurysms treated were blister and dysplastic/dissecting. Procedure-related morbidity/mortality overall was 15%, and 1 death directly related to the procedure occurred. Occlusion rates were 75% and 94% at 6 months and 12 months, respectively. The authors concluded that the Pipeline device offers a feasible treatment option in acute or subacute ruptured aneurysms, especially the blister type. Ruptured giant aneurysms remain challenging for both surgical and endovascular techniques; at this stage, the Pipeline device should be used with caution in this aneurysm subtype.